MHRA approves new diagnostic agent for adult patients showing signs of cognitive impairment for Alzheimer’s disease
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 27 November 2024, approved the medicine flortaucipir (Tauvid), a radiopharmaceutical...
:max_bytes(150000):strip_icc()/doctor-in-discussion-with-mature-female-patient-97863301-56eebdd23df78ce5f8398362.jpg "Assessing Alzheimer’s and Cognitive Function")
